Asia Pacific medical simulation market will grow by 17.19% annually with a total addressable market cap of $4,976.0 million over 2020-2026 owing to growing incidences of chronic disorders and population, rising patient safety concerns, the heightened demand for minimally invasive surgery (MIS), and technological advancement.
Highlighted with 36 tables and 45 figures, this 106-page report “Asia Pacific Medical Simulation Market 2020-2026 by Product & Service (Model-based Simulation, Web-based Simulation, Simulation Training Services), Fidelity (High, Medium, Low), End User, and Country: COVID-19 Impact and Growth Opportunity” is based on a holistic research of the entire Asia Pacific medical simulation market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2016-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific medical simulation market in every aspect of the classification from perspectives of Product & Service, Fidelity, End User, and Country.
Based on Product & Service, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
Model-based Simulation
• Patient Simulation (further segmented into Manikin-based Simulation, Task Trainer Simulation, Hybrid Manikin-based simulation, Standardized Patient Simulation)
• Surgical Simulation (further split into Cardiovascular Simulators, Laparoscopic Surgical Simulators, Gynecology Simulators, Arthroscopic Surgical Simulators, Orthopedic Simulators, Endovascular Simulators, Spine Simulators, Other Surgical Simulations)
• Ultrasound Simulation (further segmented into Cardiology, Anesthesia, Intensive Care Unit, Emergency Medicine, OB/GYN, Radiology, Other Ultrasound Simulations)
Web-based Simulation
• Virtual Tutors
• Performance Recording Software
• Simulation Software
• Learning Management Software
Simulation Training Services
• Vendor-based Training
• Custom Consulting Services
• Educational Societies
Based on Fidelity, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
• Low-fidelity
• Medium-fidelity
• High-fidelity
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
• Academic Institutions & Research Centers
• Hospitals & Clinics
• Military Organizations
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2016-2026. The breakdown of key national markets by Product & Service, Fidelity, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific medical simulation market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
3D Systems Corporation
Canadian Aviation Electronics, Ltd. (CAE)
Gaumard Scientific Company
Intelligent Ultrasound Group Plc (Formerly Medaphor Group Plc)
Kyoto Kagaku Co., Ltd.
Laerdal Medical AS
Limbs & Things Ltd.
Mentice AB
Simulab Corporation
Simulaids, Inc.
Surgical Science Sweden AB
Virtamed AG
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 18
2.1 Market Size and Forecast 18
2.1.1 Impact of COVID-19 on World Economy 19
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 27
2.4 Emerging Opportunities and Market Trends 30
2.5 Porter’s Fiver Forces Analysis 34
3 Segmentation of Asia Pacific Market by Product & Service 38
3.1 Market Overview by Product & Service 38
3.2 Model-based Simulation 40
3.2.1 Patient Simulation 41
3.2.2 Surgical Simulation 42
3.2.3 Ultrasound Simulation 44
3.3 Web-based Simulation 46
3.3.1 Virtual Tutors 48
3.3.2 Performance Recording Software 49
3.3.3 Simulation Software 50
3.3.4 Learning Management Software 51
3.4 Simulation Training Services 52
3.4.1 Vendor-based Training 53
3.4.2 Custom Consulting Services 54
3.4.3 Educational Societies 55
4 Segmentation of Asia Pacific Market by Fidelity 56
4.1 Market Overview by Fidelity 56
4.2 Low-fidelity 58
4.3 Medium-fidelity 59
4.4 High-fidelity 60
5 Segmentation of Asia Pacific Market by End User 61
5.1 Market Overview by End User 61
5.2 Academic Institutions & Research Centers 63
5.3 Hospitals & Clinics 64
5.4 Military Organizations 65
5.5 Other End Users 66
6 Asia-Pacific Market 2019-2026 by Country 67
6.1 Overview of Asia-Pacific Market 67
6.2 China 70
6.3 Japan 72
6.4 India 75
6.5 Australia 77
6.6 South Korea 79
6.7 Rest of APAC Region 81
7 Competitive Landscape 83
7.1 Overview of Key Vendors 83
7.2 New Product Launch, Partnership, Investment, and M&A 86
7.3 Company Profiles 87
3D Systems Corporation 87
Canadian Aviation Electronics, Ltd. (CAE) 89
Gaumard Scientific Company 90
Intelligent Ultrasound Group Plc (Formerly Medaphor Group Plc) 91
Kyoto Kagaku Co., Ltd. 92
Laerdal Medical AS 93
Limbs & Things Ltd. 94
Mentice AB 95
Simulab Corporation 96
Simulaids, Inc. 97
Surgical Science Sweden AB 98
Virtamed AG 99
8 Investing in Asia Pacific Market: Risk Assessment and Management 100
8.1 Risk Evaluation of Asia Pacific Market 100
8.2 Critical Success Factors (CSFs) 103
Related Reports and Products 106
Table 1. Snapshot of Asia Pacific Medical Simulation Market in Balanced Perspective, 2019-2026 17
Table 2. Growth Rate of World Real GDP, 2017-2021 20
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Medical Simulation Market 30
Table 4. Asia Pacific Medical Simulation Market by Product & Service, 2016-2026, $ mn 38
Table 5. Asia Pacific Medical Simulation Market: Model-based Simulation by Segment, 2016-2026, $ mn 40
Table 6. Asia Pacific Medical Simulation Market: Patient Simulation by Segment, 2016-2026, $ mn 41
Table 7. Asia Pacific Medical Simulation Market: Surgical Simulation by Segment, 2016-2026, $ mn 43
Table 8. Asia Pacific Medical Simulation Market: Ultrasound Simulation by Segment, 2016-2026, $ mn 45
Table 9. Asia Pacific Medical Simulation Market: Web-based Simulation by Segment, 2016-2026, $ mn 47
Table 10. Asia Pacific Medical Simulation Market: Simulation Training Services by Segment, 2016-2026, $ mn 52
Table 11. Asia Pacific Medical Simulation Market by Fidelity, 2016-2026, $ mn 56
Table 12. Asia Pacific Medical Simulation Market by End User, 2016-2026, $ mn 61
Table 13. APAC Medical Simulation Market by Country, 2016-2026, $ mn 68
Table 14. China Medical Simulation Market by Product & Service, 2016-2026, $ mn 71
Table 15. China Medical Simulation Market by Fidelity, 2016-2026, $ mn 71
Table 16. China Medical Simulation Market by End User, 2016-2026, $ mn 71
Table 17. Japan Medical Simulation Market by Product & Service, 2016-2026, $ mn 74
Table 18. Japan Medical Simulation Market by Fidelity, 2016-2026, $ mn 74
Table 19. Japan Medical Simulation Market by End User, 2016-2026, $ mn 74
Table 20. India Medical Simulation Market by Product & Service, 2016-2026, $ mn 76
Table 21. India Medical Simulation Market by Fidelity, 2016-2026, $ mn 76
Table 22. India Medical Simulation Market by End User, 2016-2026, $ mn 76
Table 23. Australia Medical Simulation Market by Product & Service, 2016-2026, $ mn 78
Table 24. Australia Medical Simulation Market by Fidelity, 2016-2026, $ mn 78
Table 25. Australia Medical Simulation Market by End User, 2016-2026, $ mn 78
Table 26. South Korea Medical Simulation Market by Product & Service, 2016-2026, $ mn 80
Table 27. South Korea Medical Simulation Market by Fidelity, 2016-2026, $ mn 80
Table 28. South Korea Medical Simulation Market by End User, 2016-2026, $ mn 80
Table 29. Medical Simulation Market in Rest of APAC by Country, 2016-2026, $ mn 82
Table 30. 3D Systems Corporation: Company Snapshot 87
Table 31. 3D Systems Corporation: Business Segmentation 87
Table 32. 3D Systems Corporation: Product Portfolio 88
Table 33. 3D Systems Corporation: Revenue, 2016-2018, $ mn 88
Table 34. 3D Systems Corporation: Recent Developments 88
Table 35. Risk Evaluation for Investing in Asia Pacific Market, 2019-2026 101
Table 36. Critical Success Factors and Key Takeaways 104
